tesaglitazar has been researched along with gw 9578 in 1 studies
| Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (gw 9578) | Trials (gw 9578) | Recent Studies (post-2010) (gw 9578) |
|---|---|---|---|---|---|
| 74 | 13 | 25 | 19 | 0 | 2 |
| Protein | Taxonomy | tesaglitazar (IC50) | gw 9578 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.55 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HK; Dong Koo, K; Ho Woo, S; Hur, GC; Joo Yim, H; Kim, GT; Kim, KH; Kim, SH; Lee, CS; Oon Han, H; Sung Koh, J | 1 |
1 other study(ies) available for tesaglitazar and gw 9578
| Article | Year |
|---|---|
Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
Topics: Animals; Area Under Curve; Biological Availability; Blood Glucose; Cell Line, Tumor; Drug Design; Humans; Hypoglycemic Agents; Indicators and Reagents; Lipids; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Molecular; Phenylpropionates; PPAR alpha; PPAR gamma; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Triglycerides | 2007 |